(INNS)
ADALIMUMAB FOSIMDESONID(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS TNF (TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY MEMBER 2, TNFSF2, TNF-ALPHA, TNFA)], HOMO SAPIENS MONOCLONAL ANTIBODY, CONJUGATED TO A DERIVATIVE OF THE GLUCOCORTICOID RECEPTOR MODULATOR (GRM) DESONIDE (24)(12) VIA A (CYSTEIN-S-YL)ACETYL-GLY-GLU LINK; GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-450) [VH (HOMO SAPIENS IGHV3-9*01 (93.9%) -(IGHD) -IGHJ4*01 (92.9%)) CDR-IMGT [8.8.14] (26-33.51-58.97-110) (1-121) -HOMO SAPIENS IGHG1*01 (100%) G1M17,1 (CH1 K120 (218) (122-219), HINGE 1-15 (220-234), CH2 (235-344), CH3 D12 (360), L14 (362) (345-449), CHS K>DEL (450)) (122-450)], (224-214')- DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') [V-KAPPA (HOMO SAPIENS IGKV1-27*01 (95.8%) -IGKJ2*01 (91.7%) L124>V (104)) CDR-IMGT [6.3.9] (27-32.50-52.89-97) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1 (153), V101 (191) (108'-214')];DIMER (230-230'':233-233'')-BISDISULFIDE(WHO)
ADALIMUMABUM FOSIMDESONIDUM(INN)